Merja Soilu-Hänninen
MD, PhD
Turku University Hospital, Division of Clinical Neurosciences mersoi@utu.fi ORCID identifier: https://orcid.org/0000-0001-6930-0229 |
Areas of expertise
Clinical neurology; neuroimmunology; multiple sclerosis risk factors, prognostic factors and treatment
Clinical neurology; neuroimmunology; multiple sclerosis risk factors, prognostic factors and treatment
Biography
MD, University of Turku 1988
PhD, University of Turku, Department of Virology, Immunobiology of central nervous system virus infections 1996
Postdoctoral Fellow, Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia 1997-1999
Specialist Degree in Neurology 2001
Adjuct Professor of Clinical Neurology 2008
Inverstigator in several clinical MS trials
Chair of the Finnish MS registry 2016-
General Neurology Section Head, Turku University Hospital, Division of Clinical Neurosciences 2017-
Research
Multiple sclerosis risk factors, prognostic factors and epidemiology.
Imaging of brain atrophy in multiple sclerosis.
Teaching
Course of medical pedagogics 2011-2012
Supervisor of several PhD student
Publications 
4 of 4
- Parechovirus infection preceding Guillain–Barré syndrome (2012)
- Journal of NeuroVirology
(A1 Refereed original research article in a scientific journal) - Unenaikainen kohtauksellinen tukehtumisen tunne - diagnostinen haaste (2012)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Simvastatin as add-on therapy to interferon B-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial (2011)
- Lancet Neurology
(A1 Refereed original research article in a scientific journal) - CHARACTERIZATION OF CD4+T CELLS SPECIFIC FOR GLUTAMIC ACID DECARBOXYLASE (GAD65) AND PROINSULIN IN A PATIENT WITH EPILEPSY AND STIFF-PERSON SYNDROME, BUT WITHOUT TYPE 1 DIABETES (2010)
- Epilepsia
(Other publication) - Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes (2010)
- Diabetes/Metabolism Research and Reviews
(A1 Refereed original research article in a scientific journal) - C-reactive protein and seizure in focal epilepsy: Avideo-EEG study (2010)
- Epilepsia
(A4 Refereed article in a conference publication ) - Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases (2010)
- Acta Neurologica Scandinavica
(A1 Refereed original research article in a scientific journal) - Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis (2010)
- Journal of the Neurological Sciences
(A1 Refereed original research article in a scientific journal) - T2-weighted high-intensity signals in the basal ganglia as an interesting image finding in Unverricht-Lundborg disease (2010)
- Epilepsy Research
(A1 Refereed original research article in a scientific journal) - Hyaluronate receptor (CD44) and integrin α4 (CD49d) are up-regulated on T cells during MS relapses (2005)
- Journal of Neuroimmunology
(A1 Refereed original research article in a scientific journal) - Molecular mechanisms regulating motor neuron development and degeneration (1999)
- Molecular Neurobiology
(A1 Refereed original research article in a scientific journal) - New treatments for multiple sclerosis (1999) Kilpatrick T., Soilu-Hänninen M.
(A1 Refereed original research article in a scientific journal) - Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium (1997)
- Journal of NeuroVirology
(A1 Refereed original research article in a scientific journal) - Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes (1995)
- Journal of Neuroimmunology
(A1 Refereed original research article in a scientific journal)
UTU Research Portal